Etanercept: all 257 studies that test it

Page 2 of 3. Open to participants first (13), then studies with results posted, then the rest; newest registration first within each.

• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)CompletedNCT00224874Phase 2Results posted
• Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic AdenocarcinomaCompletedNCT00201838Phase 1/2Results posted
• Study Evaluating Etanercept in the Treatment of Subjects With PsoriasisCompletedNCT00195507Phase 4Results posted
• Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid ArthritisCompletedNCT00195494Phase 4Results posted
• Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque PsoriasisCompletedNCT00141921Phase 3Results posted
• Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)CompletedNCT00141739Phase 2Results posted
• Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell TransplantCompletedNCT00141726Phase 2Results posted
• REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)CompletedNCT00127842Phase 4Results posted
• Azacitidine and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNCT00118287Phase 1/2Results posted
• A Pilot Study of Etanercept in DermatomyositisCompletedNCT00112385Phase 1Results posted
• Etanercept for Treatment of HidradenitisCompletedNCT00107991Phase 2Results posted
• Etanercept (Enbrel®) in Psoriasis - PediatricsCompletedNCT00078819Phase 3Results posted
• Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid ArthritisTerminatedNCT00078806Phase 3Results posted
• Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal InjuryTerminatedNCT00031551Phase 2Results posted
• REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)Status unknownNCT05164198Phase 4
• Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive ImagingStatus unknownNCT05135312Phase 4
• A Study of Nipocalimab With Co-administration of Etanercept or Hydroxychloroquine in Healthy ParticipantsCompletedNCT04973566Phase 1
• Study to Assess the Safety and Efficacy of Enbrel Administered by Sofusa DoseConnect for Rheumatoid ArthritisStatus unknownNCT04559412Phase 1
• Capability of Tofacitinib or Etanercept to Accelerate Tapering of NSAID and Treat-to-target Guided De-escalation of Corticosteroids in RA PatientsCompletedNCT04485325Phase 4
• Understanding GWI: Integrative ModelingStatus unknownNCT04255498Phase 1
• TNF and Glucocorticoid Antagonist for GWI Associated Multi-symptom Disease Homeostasis ResetCompletedNCT04254627Phase 1
• Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and EnbrelStatus unknownNCT04079374Phase 3
• Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDsStatus unknownNCT04077957Phase 4
• TNF-α Treatment of Blast-Induced TinnitusActive, not recruitingNCT04066348Phase 2
• Targeted Treatment Early With Etanercept + Methotrexate vs.T2T Care for DMARD-naïve Early RA Patients Based on naïve T-cell StratificationStatus unknownNCT03813771Phase 4
• Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in BangladeshStatus unknownNCT03504072Phase 4
• Long Term Efficacy, Safety and Immunogenicity of Enerceptan in Rheumatoid Arthritis ( GEMENE002 )Status unknownNCT03403140Phase 3
• Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male SubjectsCompletedNCT03273088Phase 1
• An Multicentre Clinical Study to Evaluate the Usability and Safety of the Autoinjector and Pre-filled Syringe of SB4 in Subjects With Rheumatoid ArthritisCompletedNCT03193957Phase 2
• Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male SubjectsCompletedNCT03193203Phase 1
• Prediction of the Answer to the Treatment by Biotherapies for Naive Spondyloarthritis by Combinatorial Analysis of Serum BiomarkersCompletedNCT03033095Not applicable
• Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type PsoriasisStatus unknownNCT02999776Phase 1
• NATIENS: Optimal Management and Mechanisms of SJS/TENCompletedNCT02987257Phase 3
• A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With SpondyloarthritisCompletedNCT02960035Phase 4
• Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up StudyCompletedNCT02915354Phase 4
• Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"Status unknownNCT02878161Phase 4
• Treatment Tapering in JIA With Inactive DiseaseCompletedNCT02840175Phase 3
• Omental Islet TransplantCompletedNCT02821026Phase 1/2
• Efficacy of Subcutaneous Injection of Etanercept for Moderate and Severe Knee OsteoarthritisStatus unknownNCT02722811Not applicable
• Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee OsteoarthritisStatus unknownNCT02722772Not applicable
• Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque PsoriasisStatus unknownNCT02701205Phase 3
• A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing SpondylitisTerminatedNCT02685904Phase 3
• Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus ErythematosusCompletedNCT02656082Phase 2
• Dose Reduction of Etanercept in Patients With Ankylosing SpondylitisStatus unknownNCT02638896Phase 4
• Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch StudyStatus unknownNCT02489760Phase 4
• Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion ProteinCompletedNCT02364479Phase 4
• Safety and Efficacy of Etanercept in Patients With PsoriasisStatus unknownNCT02258282Not applicable
• Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing SpondylitisStatus unknownNCT02132234Phase 4
• ASIS for Enbrel in Plaque PsoriasisStatus unknownNCT02112097Phase 1/2
• Etanercept in Rheumatoid Arthritis and Vascular InflammationTerminatedNCT02109289Phase 4
• TNF-alpha Inhibition in CRPS: A Randomized Controlled TrialWithdrawnNCT02031211Not applicable
• Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing SpondylitisCompletedNCT01934933Phase 4
• Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male VolunteersCompletedNCT01894412Phase 1
• Safety and Efficacy Study of Etanercept for Aneurysmal Subarachnoid HemorrhageWithdrawnNCT01865630Phase 1
• Stopping TNF Alpha Inhibitors in Rheumatoid ArthritisActive, not recruitingNCT01793519Phase 4
• Limitation of Ischemic Injury of a Kidney Stored in Machine Perfusion in Hypothermia - Evaluation of the Impact on Kidney Allograft FunctionCompletedNCT01731457Phase 2
• Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue SyndromeTerminatedNCT01730495Phase 2
• Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®CompletedNCT01725620Phase 1
• Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's DiseaseCompletedNCT01716637Phase 1
• A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RAStatus unknownNCT01709760Phase 3
• Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male VolunteersStatus unknownNCT01635686Phase 1
• Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid ArthritisTerminatedNCT01602302Phase 4
• Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy SubjectsCompletedNCT01431404Phase 1
• Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid ArthritisWithdrawnNCT01394913Phase 3
• Etanercept Treating Patient With Acute ST Segment Elevated Myocardial InfarctionStatus unknownNCT01372930Phase 4
• Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)CompletedNCT01303874Phase 4
• SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.CompletedNCT01295151Phase 4
• Etanercept (Enbrel) in Ankylosing SpondylitisStatus unknownNCT01289743Phase 2
• Etanercept (Enbrel) in Undifferentiated SpondyloarthritisStatus unknownNCT01289730Phase 2
• Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic ArthritisStatus unknownNCT01287715Phase 4
• Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA PatientsCompletedNCT01270997Phase 3
• Evaluation of Lymphocytic Infiltrate, Dendritic Cells and Cytokines Expression in Psoriatic Lesion and Normal Skin Before and After TNF Alfa Inhibitors TherapyStatus unknownNCT01237262Phase 4
• Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®CompletedNCT01145950Phase 1
• An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept UseStatus unknownNCT01132235Phase 4
• Safety and Tolerability of Etanercept in Alzheimer's DiseaseCompletedNCT01068353Phase 2
• Safety and Pharmacokinetic Characteristics of HD203 in Healthy Male VolunteersCompletedNCT01044836Phase 1
• Etanercept for the Treatment of Chronic UrticariaWithdrawnNCT01030120Phase 2/3
• Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow EmigrantsWithdrawnNCT01009879Phase 4
• Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid ArthritisCompletedNCT01000441Phase 4
• Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic TreatmentsCompletedNCT00967538Phase 4
• Pilot Study of Etanercept (Enbrel) in Children With Fanconi AnemiaCompletedNCT00965666Early Phase 1
• Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's DiseaseStatus unknownNCT00931957Not applicable
• Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)Status unknownNCT00844142Phase 2
• The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to AdalimumabCompletedNCT00833729Phase 4
• Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body MyositisCompletedNCT00802815Early Phase 1
• The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus ErythematosusStatus unknownNCT00797784Phase 2
• Islet After Kidney Transplant for Type 1 DiabetesWithdrawnNCT00784966Phase 1/2
• A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid ArthritisWithdrawnNCT00783536Phase 4
• Etanercept in New Onset Type 1 DiabetesCompletedNCT00730392Phase 1/2
• Study Evaluating Enbrel Drug Levels in Healthy Male Chinese SubjectsCompletedNCT00705042Phase 1
• Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint SynovitisCompletedNCT00678782Phase 2
• Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith EtanerceptCompletedNCT00581165Phase 4
• Study Evaluating the Efficacy and Safety of EtanerceptCompletedNCT00546533Phase 4
• Etanercept Treatment in the Early Course of Polymyalgia RheumaticaCompletedNCT00524381Phase 3
• Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male SubjectsCompletedNCT00502879Phase 1
• A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid ArthritisCompletedNCT00484237Phase 3
• Efficacy of Islet After Kidney TransplantationCompletedNCT00468117Phase 3
• Study Evaluating Etanercept in Patients With Ankylosing SpondylitisCompletedNCT00458185Phase 4
• An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing SpondylitisCompletedNCT00444340Phase 4
• Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid ArthritisCompletedNCT00443950Phase 3

← Etanercept overview